Literature DB >> 11956105

Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine.

Masashi Kato1, Kozue Takeda, Yoshiyuki Kawamoto, Toshihide Iwashita, Anwarul A Akhand, Takeshi Senga, Masahiko Yamamoto, Gen Sobue, Michinari Hamaguchi, Masahide Takahashi, Izumi Nakashima.   

Abstract

An oncogenic mutant of c-RET as a receptor-type tyrosine kinase, termed RET-MEN2A, displays both cell-transforming activity in vivo and strong catalytic activity in vitro. In this study, we compared the activities of mutant RET-MEN2A with substitutions of each of nine tyrosines for phenylalanine (Y1062F, Y1015F, Y981F, Y952F, Y928F, Y905F, Y900F, Y864F, and Y826F), which had been transfected into NIH 3T3 cells. In RET-MEN2A with the Y905F mutation, the cell-transforming activity was drastically reduced with a great reduction in the in vitro catalytic activity. Unexpectedly, we found that in vitro kinase activity was severely impaired in RET-MEN2A with Y981F, Y952F, or Y928F mutation, which displayed near-normal cell-transforming activity and only a partially impaired tyrosine phosphorylation level in vivo. Phosphoamino acid analysis actually demonstrated some increase in phosphotyrosine in the Y905F mutant but no or barely detectable increase in the Y981F, Y952F, or Y928F mutant after incubation for in vitro kinase assay. This suggested a crucial role of the Y981/Y952/Y928-linked structural integrity of the COOH end of the catalytic domain of RET in starting Y905 autophosphorylation. Interestingly, the apparent defect in intrinsic kinase activity in vitro in the Y981F, Y952F, or Y928F mutant, but not the reduction in activity in the Y905F mutant, could be partially repaired or restored by c-Src or, more extensively, by v-Src, which promoted Y905 phosphorylation in trans. A complex was shown to be formed between v-Src and RET-MEN2A through association of both with a cholesterol-rich membrane microdomain known as "a raft," possibly for efficient contact of submembranous domains of Src and RET to promote phosphorylation of Y905 of the latter. Finally, endogenous c-Src was shown to promote Y905 phosphorylation of the Y981F mutant in vivo. These results reveal a novel Src kinase-mediated repair mechanism of otherwise function-impaired mutant RET kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956105

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  RET TKI: potential role in thyroid cancers.

Authors:  Alessandro Antonelli; Poupak Fallahi; Silvia Martina Ferrari; Caterina Mancusi; Michele Colaci; Libero Santarpia; Clodoveo Ferri
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

Review 3.  c-Ret-mediated hearing losses.

Authors:  Nobutaka Ohgami; Haruka Tamura; Kyoko Ohgami; Machiko Iida; Ichiro Yajima; Mayuko Y Kumasaka; Yuji Goto; Michihiko Sone; Tsutomu Nakashima; Masashi Kato
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

4.  c-Ret-mediated hearing loss in mice with Hirschsprung disease.

Authors:  Nobutaka Ohgami; Michiru Ida-Eto; Takashi Shimotake; Naomi Sakashita; Michihiko Sone; Tsutomu Nakashima; Keiji Tabuchi; Tomofumi Hoshino; Atsuyoshi Shimada; Toyonori Tsuzuki; Masahiko Yamamoto; Gen Sobue; Mayumi Jijiwa; Naoya Asai; Akira Hara; Masahide Takahashi; Masashi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-29       Impact factor: 11.205

5.  MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.

Authors:  Jocelyn F Burke; Logan Schlosser; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-07-31       Impact factor: 5.344

6.  Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Shoko Ohnuma; Nobutaka Ohgami; Hisao Naito; Hossain U Shekhar; Yasuhiro Omata; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

7.  c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines.

Authors:  Yuichiro Ohshima; Ichiro Yajima; Kozue Takeda; Machiko Iida; Mayuko Kumasaka; Yoshinari Matsumoto; Masashi Kato
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 8.  Hearing impairments caused by genetic and environmental factors.

Authors:  Nobutaka Ohgami; Machiko Iida; Ichiro Yajima; Haruka Tamura; Kyoko Ohgami; Masashi Kato
Journal:  Environ Health Prev Med       Date:  2012-08-17       Impact factor: 3.674

9.  Molecular Network Associated with MITF in Skin Melanoma Development and Progression.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Nguyen Dinh Thang; Yuji Goto; Kozue Takeda; Machiko Iida; Nobutaka Ohgami; Haruka Tamura; Osamu Yamanoshita; Yoshiyuki Kawamoto; Keiko Furukawa; Masashi Kato
Journal:  J Skin Cancer       Date:  2011-10-20

10.  Control of genetically prescribed protein tyrosine kinase activities by environment-linked redox reactions.

Authors:  Izumi Nakashima; Yoshiyuki Kawamoto; Kozue Takeda; Masashi Kato
Journal:  Enzyme Res       Date:  2011-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.